273
Participants
Start Date
June 30, 2008
Primary Completion Date
January 31, 2010
Study Completion Date
January 31, 2010
Etanercept
ETN 50 mg QW + PBO QW for 12 weeks followed by ETN 50 mg QW for 12 weeks.
Etanercept
ETN 50 mg BIW for 12 weeks folowed ETN 50 mg QW for 12 weeks.
Pfizer Investigational Site, Taipei TOC
Pfizer Investigational Site, Taipei
Pfizer Investigational Site, Vienna
Pfizer Investigational Site, Budapest
Pfizer Investigational Site, San Miguel
Pfizer Investigational Site, Miskolc
Pfizer Investigational Site, Debrecen
Pfizer Investigational Site, Liège
Pfizer Investigational Site, Szeged
Pfizer Investigational Site, Ghent
Pfizer Investigational Site, Santiago de Compostela
Pfizer Investigational Site, Athens
Pfizer Investigational Site, Hamburg
Pfizer Investigational Site, Kiel
Pfizer Investigational Site, Fuenlabrada
Pfizer Investigational Site, Bochum
Pfizer Investigational Site, Zapopan
Pfizer Investigational Site, Valencia
Pfizer Investigational Site, Osnabrück
Pfizer Investigational Site, Frankfurt am Main
Pfizer Investigational Site, Monterrey
Pfizer Investigational Site, Monterrey
Pfizer Investigational Site, L’Aquila
Pfizer Investigational Site, München
Pfizer Investigational Site, Catanzaro
Pfizer Investigational Site, Erlangen
Pfizer Investigational Site, Capital Federal
Pfizer Investigational Site, Capital Federal
Pfizer Investigational Site, Feldkirch
Pfizer Investigational Site, Bangkok
Pfizer Investigational Site, Brussels
Pfizer Investigational Site, Jihlava
Pfizer Investigational Site, Ostrava- Poruba
Pfizer Investigational Site, Plzen-Bory
Pfizer Investigational Site, Athens
Pfizer Investigational Site, Gangnam-gu
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Barcelona
Lead Sponsor
Pfizer
INDUSTRY